BackgroundThe economic evaluation of health interventions is important in priority setting. Several guidance documents exist to support the conduct of economic evaluations, however, there is limited guidance for the evaluation of non-medical interventions. For tuberculosis (TB), where equity-deserving groups are disproportionately impacted, assessing interventions aimed at addressing social risk factors is necessary to effectively reduce TB burden.ObjectiveThis scoping review seeks to assess the existing literature on model-based economic evaluations of TB interventions to gauge the extent to which non-medical interventions have been evaluated in low-TB-incidence jurisdictions. As a secondary objective, this review aims to characterize key ...
Introduction: Bacillus Calmette-Guerin (BCG) is the only licensed vaccine for tuberculosis, but its ...
BACKGROUND: Methods for determining cost-effectiveness of different treatments are well established,...
BACKGROUND: Methods for determining cost-effectiveness of different treatments are well established,...
Tuberculosis (TB) is a leading cause of death in developing countries and an important health threat...
textabstractTuberculosis (TB) is a leading cause of death in developing countries and an important h...
Item does not contain fulltextTuberculosis (TB) is a leading cause of death in developing countries ...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Timely diagnosis and treatment of latent tuberculosis infection (LTBI) through screening remains a k...
Objective. The End TB Strategy advocates socioeconomic support for TB-affected households but there ...
Since treatment of active disease remains the priority for tuberculosis control, donors and governme...
OBJECTIVE: To quantify the impact of cash transfer and microfinance interventions on a selected list...
Tuberculosis (TB) and poverty are inextricably linked. Catastrophic costs of TB illness drive TB-aff...
BackgroundIllness-related costs for patients with tuberculosis (TB) ≥20% of pre-illness annual house...
Introduction: Bacillus Calmette-Guerin (BCG) is the only licensed vaccine for tuberculosis, but its ...
BACKGROUND: Methods for determining cost-effectiveness of different treatments are well established,...
BACKGROUND: Methods for determining cost-effectiveness of different treatments are well established,...
Tuberculosis (TB) is a leading cause of death in developing countries and an important health threat...
textabstractTuberculosis (TB) is a leading cause of death in developing countries and an important h...
Item does not contain fulltextTuberculosis (TB) is a leading cause of death in developing countries ...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Timely diagnosis and treatment of latent tuberculosis infection (LTBI) through screening remains a k...
Objective. The End TB Strategy advocates socioeconomic support for TB-affected households but there ...
Since treatment of active disease remains the priority for tuberculosis control, donors and governme...
OBJECTIVE: To quantify the impact of cash transfer and microfinance interventions on a selected list...
Tuberculosis (TB) and poverty are inextricably linked. Catastrophic costs of TB illness drive TB-aff...
BackgroundIllness-related costs for patients with tuberculosis (TB) ≥20% of pre-illness annual house...
Introduction: Bacillus Calmette-Guerin (BCG) is the only licensed vaccine for tuberculosis, but its ...
BACKGROUND: Methods for determining cost-effectiveness of different treatments are well established,...
BACKGROUND: Methods for determining cost-effectiveness of different treatments are well established,...